|
1
|
Nielsen PR, Nietlispach D, Mott HR, et al:
Structure of the HP1 chromodomain bound to histone H3 methylated at
lysine 9. Nature. 416:103–107. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ayoub N, Jeyasekharan AD and Venkitaraman
AR: Mobilization and recruitment of HP1: a bimodal response to DNA
breakage. Cell Cycle. 8:2945–2950. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dialynas GK, Vitalini MW and Wallrath LL:
Linking Heterochromatin Protein 1 (HP1) to cancer progression.
Mutat Res. 647:13–20. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang R and Adams PD: Heterochromatin and
its relationship to cell senescence and cancer therapy. Cell Cycle.
6:784–789. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kwon SH and Workman JL: The changing faces
of HP1: from heterochromatin formation and gene silencing to
euchromatic gene expression: HP1 acts as a positive regulator of
transcription. Bioessays. 33:280–289. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Minc E, Allory Y, Worman HJ, Courvalin JC
and Buendia B: Localization and phosphorylation of HP1 proteins
during the cell cycle in mammalian cells. Chromosoma. 108:220–234.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nielsen AL, Oulad-Abdelghani M, Ortiz JA,
Remboutsika E, Chambon P and Losson R: Heterochromatin formation in
mammalian cells: interaction between histones and HP1 proteins. Mol
Cell. 7:729–739. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nielsen AL, Ortiz JA, You J, et al:
Interaction with members of the heterochromatin protein 1 (HP1)
family and histone deacetylation are differentially involved in
transcriptional silencing by members of the TIF1 family. EMBO J.
18:6385–6395. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hediger F and Gasser SM: Heterochromatin
protein 1: don’t judge the book by its cover! Curr Opin Genet Dev.
16:143–150. 2006.PubMed/NCBI
|
|
10
|
Piacentini L, Fanti L, Berloco M, Perrini
B and Pimpinelli S: Heterochromatin protein 1 (HP1) is associated
with induced gene expression in Drosophila euchromatin. J
Cell Biol. 161:707–714. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pomeroy SL, Tamayo P, Gaasenbeek M, et al:
Prediction of central nervous system embryonal tumour outcome based
on gene expression. Nature. 415:436–442. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wasenius VM, Hemmer S, Kettunen E,
Knuutila S, Franssila K and Joensuu H: Hepatocyte growth factor
receptor, matrix metalloproteinase-11, tissue inhibitor of
metalloproteinase-1, and fibronectin are up-regulated in papillary
thyroid carcinoma: a cDNA and tissue microarray study. Clin Cancer
Res. 9:68–75. 2003.
|
|
13
|
Kirschmann DA, Lininger RA, Gardner LM, et
al: Down-regulation of HP1Hsalpha expression is associated with the
metastatic phenotype in breast cancer. Cancer Res. 60:3359–3363.
2000.PubMed/NCBI
|
|
14
|
Thomsen R, Christensen DB, Rosborg S,
Linnet TE, Blechingberg J and Nielsen AL: Analysis of HP1α
regulation in human breast cancer cells. Mole Carcinog. 50:601–613.
2011.
|
|
15
|
Nishimura K, Hirokawa YS, Mizutani H and
Shiraishi T: Reduced heterochromatin protein 1-beta (HP1beta)
expression is correlated with increased invasive activity in human
melanoma cells. Anticancer Res. 26:4349–4356. 2006.PubMed/NCBI
|
|
16
|
Lukásová E, Koristek Z, Falk M, et al:
Methylation of histones in myeloid leukemias as a potential marker
of granulocyte abnormalities. J Leukoc Biol. 77:100–111.
2005.PubMed/NCBI
|
|
17
|
Vihinen P and Kähäri VM: Matrix
metalloproteinases in cancer: prognostic markers and therapeutic
targets. Int J Cancer. 99:157–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gupta A, Kaur CD, Jangdey M and Saraf S:
Matrix metalloproteinase enzymes and their naturally derived
inhibitors: novel targets in photocarcinoma therapy. Ageing Res
Rev. 13:65–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Egeblad M and Werb Z: New functions for
the matrix metalloproteinases in cancer progression. Nat Rev
Cancer. 2:161–174. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
McCawley LJ and Matrisian LM: Matrix
metalloproteinases: they’re not just for matrix anymore! Curr Opin
Cell Biol. 13:534–540. 2001.
|
|
21
|
Ikebe T, Shinohara M, Takeuchi H, et al:
Gelatinolytic activity of matrix metalloproteinase in tumor tissues
correlates with the invasiveness of oral cancer. Clin Exp
Metastasis. 17:315–323. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thomas GT, Lewis MP and Speight PM: Matrix
metalloproteinases and oral cancer. Oral Oncol. 35:227–233. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
du Chéné I, Basyuk E, Lin YL, et al:
Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1
transcriptional silencing and post-integration latency. EMBO J.
26:424–435. 2007.PubMed/NCBI
|
|
24
|
Kwon S, Zhang Y and Matthias P: The
deacetylase HDAC6 is a novel critical component of stress granules
involved in the stress response. Genes Dev. 21:3381–3394. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lafleur MA, Handsley MM and Edwards DR:
Metalloproteinases and their inhibitors in angiogenesis. Expert Rew
Mol Med. 5:1–39. 2003.PubMed/NCBI
|
|
26
|
James TC and Elgin SC: Identification of a
nonhistone chromosomal protein associated with heterochromatin in
Drosophila melanogaster and its gene. Mol Cell Biol.
6:3862–3872. 1986.PubMed/NCBI
|
|
27
|
Lomberk G, Bensi D, Fernandez-Zapico ME
and Urrutia R: Evidence for the existence of an HP1-mediated
subcode within the histone code. Nat Cell Biol. 8:407–415. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
De Koning L, Savignoni A, Boumendil C, et
al: Heterochromatin protein 1alpha: a hallmark of cell
proliferation relevant to clinical oncology. EMBO Mol Med.
1:178–191. 2009.PubMed/NCBI
|
|
29
|
De Lange R, Burtscher H, Jarsch M and
Weidle UH: Identification of metastasis-associated genes by
transcriptional profiling of metastatic versus non-metastatic colon
cancer cell lines. Anticancer Res. 21:2329–2339. 2001.PubMed/NCBI
|
|
30
|
Norwood LE, Moss TJ, Margaryan NV, et al:
A requirement for dimerization of HP1Hsalpha in suppression of
breast cancer invasion. J Biol Chem. 281:18668–18676. 2006.
View Article : Google Scholar : PubMed/NCBI
|
